These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 26977012

  • 1. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.
    DU G, Hao C, Gu Y, Wang Z, Jiang WG, He J, Cheng S.
    Anticancer Res; 2016 Mar; 36(3):1165-73. PubMed ID: 26977012
    [Abstract] [Full Text] [Related]

  • 2. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
    Cheng S, Li Y, Yang Y, Feng D, Yang L, Ma Q, Zheng S, Meng R, Wang S, Wang S, Jiang WG, He J.
    FEBS Lett; 2013 Oct 11; 587(20):3289-95. PubMed ID: 24012959
    [Abstract] [Full Text] [Related]

  • 3. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
    Yang X, Du G, Yu Z, Si Y, Martin TA, He J, Cheng S, Jiang WG.
    Anticancer Res; 2017 Jan 11; 37(1):67-73. PubMed ID: 28011475
    [Abstract] [Full Text] [Related]

  • 4. The scaffolding protein NHERF1 sensitizes EGFR-dependent tumor growth, motility and invadopodia function to gefitinib treatment in breast cancer cells.
    Bellizzi A, Greco MR, Rubino R, Paradiso A, Forciniti S, Zeeberg K, Cardone RA, Reshkin SJ.
    Int J Oncol; 2015 Mar 11; 46(3):1214-24. PubMed ID: 25530180
    [Abstract] [Full Text] [Related]

  • 5. Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN.
    Zheng J, Dai Y, Yang Z, Yang L, Peng Z, Meng R, Xiong Y, He J.
    Oncol Rep; 2016 Jan 11; 35(1):530-7. PubMed ID: 26531778
    [Abstract] [Full Text] [Related]

  • 6. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).
    Pan Y, Wang L, Dai JL.
    Breast Cancer Res; 2006 Jan 11; 8(6):R63. PubMed ID: 17078868
    [Abstract] [Full Text] [Related]

  • 7. NHERF1 regulates gp120-induced internalization and signaling by CCR5, and HIV-1 production.
    Kuang YQ, Pang W, Zheng YT, Dupré DJ.
    Eur J Immunol; 2012 Feb 11; 42(2):299-310. PubMed ID: 22028271
    [Abstract] [Full Text] [Related]

  • 8. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y.
    Oncogene; 2010 Sep 02; 29(35):4947-58. PubMed ID: 20562913
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
    Li L, Qi L, Liang Z, Song W, Liu Y, Wang Y, Sun B, Zhang B, Cao W.
    Int J Mol Med; 2015 Jul 02; 36(1):113-22. PubMed ID: 26005723
    [Abstract] [Full Text] [Related]

  • 10. NHERF1 Suppresses Lung Cancer Cell Migration by Regulation of Epithelial-Mesenchymal Transition.
    Yang F, Gu Y, Zhao Z, Huang J, Jiang WG, Cheng S.
    Anticancer Res; 2017 Aug 02; 37(8):4405-4414. PubMed ID: 28739734
    [Abstract] [Full Text] [Related]

  • 11. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE.
    Breast Cancer Res; 2007 Aug 02; 9(5):R63. PubMed ID: 17897439
    [Abstract] [Full Text] [Related]

  • 12. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W, Zhang S, Shan C, Zhou L, Zhou Z.
    FEBS J; 2013 Aug 02; 280(16):3962-74. PubMed ID: 23786162
    [Abstract] [Full Text] [Related]

  • 13. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
    Tao T, Yang X, Qin Q, Shi W, Wang Q, Yang Y, He J.
    Int J Mol Sci; 2017 Jan 12; 18(1):. PubMed ID: 28085111
    [Abstract] [Full Text] [Related]

  • 14. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
    Du G, Gu Y, Hao C, Yuan Z, He J, Jiang WG, Cheng S.
    Oncotarget; 2016 May 17; 7(20):29440-53. PubMed ID: 27097111
    [Abstract] [Full Text] [Related]

  • 15. SHIP2 phosphoinositol phosphatase positively regulates EGFR-Akt pathway, CXCR4 expression, and cell migration in MDA-MB-231 breast cancer cells.
    Prasad NK.
    Int J Oncol; 2009 Jan 17; 34(1):97-105. PubMed ID: 19082482
    [Abstract] [Full Text] [Related]

  • 16. Involvement of nuclear NHERF1 in colorectal cancer progression.
    Mangia A, Saponaro C, Malfettone A, Bisceglie D, Bellizzi A, Asselti M, Popescu O, Reshkin SJ, Paradiso A, Simone G.
    Oncol Rep; 2012 Sep 17; 28(3):889-94. PubMed ID: 22766563
    [Abstract] [Full Text] [Related]

  • 17. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J, Liu M, Yang L, Tu G, Zhu Q, Chen M, Cheng H, Luo H, Fu W, Li Z, Yang G.
    Breast Cancer Res; 2015 May 21; 17(1):69. PubMed ID: 25990368
    [Abstract] [Full Text] [Related]

  • 18. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
    Asanuma H, Torigoe T, Kamiguchi K, Hirohashi Y, Ohmura T, Hirata K, Sato M, Sato N.
    Cancer Res; 2005 Dec 01; 65(23):11018-25. PubMed ID: 16322251
    [Abstract] [Full Text] [Related]

  • 19. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
    Gu Y, Yu H, Hao C, Martin TA, Hargest R, He J, Cheng S, Jiang WG.
    Oncotarget; 2017 Jan 31; 8(5):7753-7765. PubMed ID: 27999191
    [Abstract] [Full Text] [Related]

  • 20. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
    Saponaro C, Malfettone A, Dell'Endice TS, Brunetti AE, Achimas-Cadariu P, Paradiso A, Mangia A.
    Cancer Biomark; 2014 Jan 31; 14(2-3):177-84. PubMed ID: 24878819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.